26278-1-AP

antibody from Proteintech Group

Targeting: CBX7

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

26278-1-AP

Provider

Proteintech Group

Product name

CBX7 antibody

Antibody type

Polyclonal

Description

CBX7 antibody (Cat. #26278-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: WB,ELISA.

Reactivity

Human, Mouse

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Nucleoporin Seh1 controls murine neocortical development via transcriptional repression of p21 in neural stem cells.

Dai W, Liu Z, Yan M, Nian X, Hong F, Zhou Z, Wang C, Fu X, Li X, Jiang M, Zhu Y, Huang Q, Lu X, Hou L, Yan N, Wang Q, Hu J, Mo W, Zhang X, Zhang L
Developmental cell 2024 Feb 26;59(4):482-495.e6

---

CBX7 Rejuvenates Late Passage Dental Pulp Stem Cells by Maintaining Stemness and Pro-angiogenic Ability.

Wu Y, Li B, Yu D, Zhou Z, Shen M, Jiang F
Tissue engineering and regenerative medicine 2023 Jun;20(3):473-488

---

Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer.

Ren J, Yu H, Li W, Jin X, Yan B
British journal of cancer 2023 Jan;128(2):232-244

---

Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells.

Ma Y, Liu L, Wei Z, Zhu M, Huang L, Wang S, Yi X, Ying F, Zhao S, Cai J, Wang Z, Sun S
Molecular carcinogenesis 2023 Apr;62(4):479-492

---

Comprehensive analysis reveals the value of the expression of chromobox family members for bladder urothelial carcinoma prognosis.

Meng X, Cao R, Liu X, Fu B, Luo L, Jiang M, Wang K, Liu Y, Zhu Q, Yang C, Zhou L
Oncology letters 2023 Apr;25(4):172

---

The RNF26/CBX7 axis modulates the TNF pathway to promote cell proliferation and regulate sensitivity to TKIs in ccRCC.

Liu W, Wang H, Jian C, Li W, Ye K, Ren J, Zhu L, Wang Y, Jin X, Yi L
International journal of biological sciences 2022;18(5):2132-2145

---

Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer.

Fang X, Wang J, Chen J, Zhuang M, Huang T, Chen Z, Huang Y, Zheng B, Wang X
Frontiers in genetics 2022;13:851390

---

Circ_0006790 carried by bone marrow mesenchymal stem cell-derived exosomes regulates S100A11 DNA methylation through binding to CBX7 in pancreatic ductal adenocarcinoma.

Gao G, Wang L, Li C
American journal of cancer research 2022;12(5):1934-1959

---

CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer.

Ren W, Ren J, Zhang N, Liu X, Deng Y, Jiang Y, Yan B, Xiao X, Yu H
Biochemical and biophysical research communications 2022 Jul 12;613:12-18

---

CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma.

Yang Y, Hu Z, Sun H, Yu Q, Yang L, Yin F, Sun Y, Pu L, Zhu X, Li S, Chen X, Zhao Y
OncoTargets and therapy 2021;14:5477-5492